Lessell S: Corticosteroid treatment of acute optic neuritis. N Engl J Med 326:634, 1992.
Lightman S, McDonald WI, Bird AC, et al: Retinal venous sheathing in optic neuritis. Brain 110:405, 1987.
Lindå H, von Heijne A, Major EO, et al: Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081, 2009.
Lublin FD, Cofield SS, Cutter GR, et al: Randomized study combining interferon and glatiramer acetate in multiple sclerosis. Ann Neurol 73:327, 2013.
Lucchinetti CF, Brück W, Parisi J, et al: Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707, 2000.
Lucchinetti CF, Kiers L, O’Duffy A, et al: Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49:1413, 1997.
Lucchinetti CF, Mandler RN, McGovern D, et al: A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125:1450, 2002.
Lucchinetti CF, Popescu BF, Bunyan RF, et al: Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188, 2011.
Mandler RN, Ahmed W, Dencoff JE: Devic’s neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219, 1998.
Mathews WB: Paroxysmal symptoms in multiple sclerosis. J Neuro Neurosurg Psychiat 38:617, 1975.
Mayr WT, Pittock SJ, McClelland RL, et al: Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 61:1373, 2003.
McAlpine D, Compston MD: Some aspects of the natural history of disseminated sclerosis. Q J Med 21:135, 1952.
McAlpine D, Lumsden CE, Acheson ED: Multiple Sclerosis: A Reappraisal, 2nd ed. Edinburgh, UK, Churchill Livingstone, 1972.
McDonald WI, Compston A, Edan G, et al: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121, 2001.
Mealy MA, Wingerchuk DM, Palace J, Greenberg BM, Levy M. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: Multicenter study of treatment efficacy. JAMA Neurol 2014;71:324–330.
Mendell JR, Kolkin S, Kissel JT, et al: Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 37:1291, 1987.
Merle H, Olindo S, Jeannin S, et al: Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 2012;130:858–862.